Table 3. Tumour porphyrin synthesis from ALA and ALA derivatives after systemic administration to mice and ALA content.
nmol ALA or ALA derivatives/g tissue at 10 min | nmol ALA or ALA derivatives/g tissue at 3 h | nmol porphyrins/g tissue at 3 h | |
---|---|---|---|
Control | 12.5±0.9 | 12.5±0.9 | 0.36±0.05 |
ALA | 170.2±8.4 | 15.11±5.1 | 15.9±1.12 |
He-ALA | 56.3±10.3 | 12.9±1.5 | 3.11±0.42 |
Undecanoyl-ALA | 28.2±3.1 | 11.2±3.4 | 2.64±0.23 |
THP-ALA | 37.0±5.2 | 17.8±2.8 | 8.83±0.95 |
In all, 3.3 mg ALA, 5 mg He-ALA, 6.3 mg undecanoyl-ALA and 5.2 mg THP-ALA were administrated i.p. to mice. After 10 min, the ALA content was determined and after 3 h ALA and porphyrins were quantified in tumour. PBG levels at 10 min and 3 h were undetectable.